About NEW LIFE LABORATORIES PVT. LTD.
NEW LIFE LABORATORIES PVT. LTD. is a leading manufacturer of Homeopathic Medicines, recognized for our commitment to quality and innovation. Founded on January 31, 1999, by Dr. M. Idris Siddiqui, who has over 52 years of experience, and Dr. Mohd. Ilyas Siddiqui, with more than 45 years in the field, we have established a strong reputation in the pharmaceutical industry. Our product range includes a diverse array of homeopathic remedies such as Angio-N-Gold Drop, Nl Alfalfa Tonic, and various syrups and tablets designed to address common health concerns.
Our manufacturing processes adhere to stringent GMP and ISO-9001 standards, ensuring that every product is crafted in a bacteria-free and dust-free environment. We utilize the latest techniques and high-quality raw materials to produce effective homeopathic solutions. Our commitment to research and development allows us to continually expand our product offerings and improve existing formulations.
We proudly serve clients across multiple states in India, including Maharashtra, Uttar Pradesh, and Punjab, and our products have gained the trust of numerous homeopathic practitioners nationwide. At NEW LIFE LABORATORIES, we are dedicated to enhancing the health and well-being of our customers through safe and effective homeopathic treatments.
Why Choose Us?
Choosing NEW LIFE LABORATORIES PVT. LTD. means opting for excellence in homeopathic medicine manufacturing. Here are some reasons to partner with us:
- Expertise: Our founders bring decades of experience in homeopathy, ensuring high standards in product development.
- Quality Assurance: We are certified with GMP and ISO-9001, reflecting our commitment to quality and safety.
- Innovative Products: Our extensive range of homeopathic medicines is developed using the latest techniques and research.
- Customer-Centric Approach: We prioritize the needs of our clients, providing tailored solutions to meet their specific requirements.
- Nationwide Reach: Our products are trusted by practitioners and patients across various states, ensuring broad accessibility.